Zhengye Biotechnology Holding (ZYBT) Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Current Assets data on file, last reported at $19.4 million in Q4 2025.

• Current Assets for Q4 2025 came in at $19.4 million, down 21.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.4 million (down 21.62% YoY), and the FY2025 annual result was $19.6 million, down 19.23% from the prior year.
• Current Assets retreated to $19.4 million in Q4 2025 per ZYBT's latest filing, from $28.1 million in the prior quarter.
• Over five years, Current Assets peaked at $28.1 million in Q2 2025 and troughed at $19.4 million in Q4 2025.
• A 3-year average of $24.6 million and a median of $25.5 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets fell 5.95% in 2024, then slipped 21.62% in 2025.
• A 3-year view of Current Assets shows it stood at $26.3 million in 2023, then fell by 5.95% to $24.7 million in 2024, then retreated by 21.62% to $19.4 million in 2025.
• Business Quant data shows ZYBT's Current Assets at $19.4 million in Q4 2025, $28.1 million in Q2 2025, and $24.7 million in Q4 2024.